Analytica Limited (ALT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Analytica Limited (ALT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12097
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Analytica Limited (Analytica) is a specialty diagnostic and laboratory equipment company. It designs, develops and supplies Class I and II medical devices. The company provides women’s health systems and intravenous (IV) medication delivery systems. Its major products include PeriCoach e-health treatment system for women who suffer from stress urinary incontinence; and AutoStart infusion system, which monitors and refills burettes in intravenous fluid infusion. Analytica licensed its AutoStart Burette and other burette intellectual property to Medical Australia Limited for distribution in the Australian market. The company sells its products through distributors in Australia, New Zealand, the UK, Ireland and the US. Analytica is headquartered in Maryborough, Queensland, Australia.

Analytica Limited (ALT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Analytica Limited, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Analytica Limited, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Analytica Limited, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Analytica Limited, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Analytica Limited, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Analytica Limited, Medical Equipment, Deal Details 10
Partnerships 10
Analytica Enters Into Co-Marketing Agreement With Taiwan Allied Dragon For Auto Start Burette 10
Equity Offering 11
Analytica Raises Funds through Private Placement of Shares 11
Analytica Raises USD1.3 Million in Rights Offering of Shares 12
Analytica to Raise USD0.05 Million in Private Placement of Shares 13
Analytica to Raise Funds through Private Placement of Shares 14
Analytica Raises USD1.35 Million in Rights Offering of Shares 15
Analytica Completes Rigths Offering Of Shares For US$1.7 Million 16
Analytica Limited – Key Competitors 17
Analytica Limited – Key Employees 18
Analytica Limited – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Apr 30, 2018: Analytica: Appendix 4C – Quarterly Cash Flow Report 20
Jul 31, 2017: Analytica: Quarterly Cash Flow Report 21
Corporate Communications 23
Sep 27, 2017: Analytica: Update – Progress of Corporate Plan 23
May 23, 2017: Analytica: Appointment of Dr. Peter B. Corr as Director 24
Legal and Regulatory 26
Oct 03, 2018: Analytica announce change in registered office and mailing address 26
Sep 03, 2018: Analytica: Change in registered office and mailing address 28
Product News 29
May 11, 2017: PeriCoach granted patent protection in Australia 29
Other Significant Developments 30
Jul 31, 2018: Analytica: Appendix 4C – Quarterly cash flow report for period ended 30 June 2018 30
Jan 29, 2018: Analytica: Quarterly Cash Flow Report Of 31st December 2017 31
Oct 31, 2017: Analytica : Quarterly Cash Flow Report 2017 32
Jan 31, 2017: Analytica Releases Quarterly Cash Flow Report 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Analytica Limited, Medical Equipment, Key Facts, 2018 2
Analytica Limited, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Analytica Limited, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Analytica Limited, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Analytica Limited, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Analytica Limited, Deals By Market, 2012 to YTD 2018 8
Analytica Limited, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Analytica Enters Into Co-Marketing Agreement With Taiwan Allied Dragon For Auto Start Burette 10
Analytica Raises Funds through Private Placement of Shares 11
Analytica Raises USD1.3 Million in Rights Offering of Shares 12
Analytica to Raise USD0.05 Million in Private Placement of Shares 13
Analytica to Raise Funds through Private Placement of Shares 14
Analytica Raises USD1.35 Million in Rights Offering of Shares 15
Analytica Completes Rigths Offering Of Shares For US$1.7 Million 16
Analytica Limited, Key Competitors 17
Analytica Limited, Key Employees 18
Analytica Limited, Other Locations 19
Analytica Limited, Subsidiaries 19

List of Figures
Analytica Limited, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Analytica Limited, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Analytica Limited, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Analytica Limited, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Analytica Limited, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Analytica Limited, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Analytica Limited, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Analytica Limited, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Analytica Limited (ALT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LMI Aerospace, Inc.:企業の戦略的SWOT分析
    LMI Aerospace, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Cerus Energy Group Ltd (CEA):企業の財務・戦略的SWOT分析
    Summary Cerus Energy Group Ltd (Cerus Energy), formerly Petrostar Petroleum Corp is an oil and gas company that produces methanol, DME, and petroleum and natural gas. The company offers deep well disposal, storage and terminalling services, and well management services. Its well management services …
  • Heidrick & Struggles International Inc (HSII):企業の財務・戦略的SWOT分析
    Summary Heidrick & Struggles International Inc (Heidrick & Struggles) is a provider of business advisory and consulting services. The company’s services comprise executive search, leadership consulting, and culture shaping services. Its leadership consulting services include leadership assessment an …
  • Great Western Bancorp Inc.:企業の戦略・SWOT・財務情報
    Great Western Bancorp Inc. - Strategy, SWOT and Corporate Finance Report Summary Great Western Bancorp Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Chembio Diagnostic Inc (CEMI):医療機器:M&Aディール及び事業提携情報
    Summary Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technol …
  • Innospec Inc. (IOSP):石油・ガス:M&Aディール及び事業提携情報
    Summary Innospec Inc (Innospec) is a provider of specialty chemicals. It blends, manufactures and supplies fuel additives and other specialty chemicals. Innospec’s product portfolio includes stabilizers, detergents, cold flow improvers, lubricity improvers, corrosion inhibitors, conductivity improve …
  • Gildan Activewear Inc (GIL):企業の財務・戦略的SWOT分析
    Gildan Activewear Inc (GIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Enanta Pharmaceuticals Inc (ENTA):企業の財務・戦略的SWOT分析
    Summary Enanta Pharmaceuticals Inc (Enanta) is a biotechnology company that discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company’s lead product candidate includes EDP-305, a farnesoid X receptor (FXR) agonist intended for the treatment of …
  • Grupo Industrial Saltillo, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Grupo Industrial Saltillo, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Industrial Saltillo, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Protokinetix Inc (PKTX):企業の財務・戦略的SWOT分析
    Summary ProtoKinetix Inc (ProtoKinetix) is a biotechnology company that develops solutions for cell survival and health. The company develops anti-aging glycopeptides used to protect cell lines including hela cells, neonatal fibroblasts, adult fibroblast, human neuronal stem cells, CD34+ cells and k …
  • Ahli Bank Qsc:企業の戦略・SWOT・財務分析
    Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report Summary Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Rosinter Restaurants Holding Ojsc:企業の戦略・SWOT・財務分析
    Rosinter Restaurants Holding Ojsc - Strategy, SWOT and Corporate Finance Report Summary Rosinter Restaurants Holding Ojsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Excision BioTherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Excision BioTherapeutics Inc (Excision BioTherapeutics) is a developer of gene editing therapeutics for the treatment of infectious diseases. The company’s products comprise EBT101, a HIV CRISPR Cas9 gRNA multiplex biologic for the prevention of Human Immunodeficiency Virus; EBT103, a PML JC …
  • P/F Atlantic Petroleum (ATLA DKK):企業の財務・戦略的SWOT分析
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • Helmerich & Payne Inc (HP):企業の財務・戦略的SWOT分析
    Helmerich & Payne Inc (HP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Scatec Solar ASA (SSO):電力:M&Aディール及び事業提携情報
    Summary Scatec Solar ASA (Scatec Solar) is an integrated independent producer of solar power that develops, builds, owns and operates solar power plants. It conducts project origination and development, project financing, design and engineering, procurement and construction management, operation and …
  • Scholastic Corporation:企業の戦略・SWOT・財務情報
    Scholastic Corporation - Strategy, SWOT and Corporate Finance Report Summary Scholastic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • IQVIA Holdings Inc (IQV):企業の財務・戦略的SWOT分析
    IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cooper Tire & Rubber Co (CTB):企業の財務・戦略的SWOT分析
    Cooper Tire & Rubber Co (CTB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Qurient Co Ltd (115180):製薬・医療:M&Aディール及び事業提携情報
    Summary Qurient Co Ltd (Qurient) is a pharmaceutical company that offers development of new drugs for unmet medical needs. The company provides portfolio of pipeline products such as Q301, Q203, Q701, 5LO INH and CDK7 INH, among others. It is developing products for the treatment of atopic dermatiti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆